Church & Dwight Q3 adj. EPS $0.79 beats outlook; vitamin impairment drives reported loss

CHURCH & DWIGHT CO INC /DE/

2024-Q3 EPS reported $1.61 revenue$4,525,100,000

Q3 net sales $1,510.6M (+3.8%); organic sales +4.3% led by volume (+3.1%).
Adjusted EPS $0.79 vs. outlook of $0.67; reported loss per share -$0.31 from $357M vitamin impairment charge.
Domestic organic +3.3%, International +8.1%, SPD +7.5%; marketing spend +80bps to 12.3% of sales.
Full-year adj. EPS growth reaffirmed at +8%; gross margin expansion raised to +110bps; cash from ops ~$1.1B.
Q4 outlook: organic sales +2-3%, adj. EPS $0.76 (+17% YoY); cautious on US consumer.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.